Health

Cushings Syndrome Market Competition by Manufacturers 2018 To 2026

Press Release

Cushing’s syndrome is a collection of symptoms and signs, which includes high blood pressure, reddish stretch marks, abdominal obesity, round red face, weak muscles, weak bones, a fat lump between the shoulders and fragile skin that heals slowly due to prolonged exposure to cortisol. Excessive cortisol-like medication such as prednisone or tumor that is produced due to excess cortisol by adrenal glands are the two basic factors that cause Cushing’s syndrome. Other tumors may also cause this disease, which are associated with inherited disorders such as multiple endocrine neoplasia type 1 and Carney complex. Most cases can be treated and cured by combination of surgery radiation or chemotherapy.

The key players dominating the global Cushing’s syndrome market

Increase in research and development in 2016, which includes development of clinical trials for RECORLEV for the treatment of endogenous Cushing’s syndrome by Strongbrigde Biopharma plc is expected to create competition and also favor the growth between various manufacture to lead the market. The key players operating in Cushing’s syndrome market include Corcept Therapeutics Inc., HRA Pharma, Strongbridge Biopharma plc. and Novartis AG.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/554

The most significant cause of Cushing’s syndrome is intake of glucocorticoids prescribed by a healthcare professional to cure other diseases such as asthma, rheumatoid arthritis or in immunosuppression after an organ transplant. Administration of synthetic ACTH can also lead to the condition. It may also occur in other animals such as cats, dogs, and horse. All the factors mentioned above are expected to favor the growth of Cushing’s syndrome market.

Cushing’s syndrome Market Taxonomy

By Drug Type

By End User

Rise in cortisol hormone fuels the growth of Cushing’s syndrome market

Hormonal disorder caused due to prolonged exposure of body’s tissue to high levels of hormone cortisol leads to Cushing’s syndrome, also called hypercortisolism. Adults aged in the age group of 20-50 years suffer from Cushing’s syndrome. It is rarely seen, though has risk of development in patient who are obese and also have type 2 diabetes, high blood pressure with poorly controlled blood glucose.

Regional growth engines that supports Cushing’s syndrome market

In terms of geography Cushing’s syndrome is segmented into North America, Europe, Asia-pacific, Middle East, Latin America and Africa. Due to presence of high income standard and health awareness in North America favors the growth of Cushing’s syndrome market. Click To Read More On Cushings Syndrome Market

RSS news